Lineage Cell Therapeutics, Inc.

NYSEAM:LCTX Stock Report

Market Cap: US$113.3m

Lineage Cell Therapeutics, Inc. Company Information

Lineage Cell Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Lineage Cell Therapeutics, Inc.
  • Ticker: LCTX
  • Exchange: NYSEAM
  • Founded: 1990
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$113.302m
  • Shares Outstanding: 188.84m
  • Website: https://www.lineagecell.com

Number of Employees

Location

  • Lineage Cell Therapeutics, Inc.
  • 2173 Salk Avenue
  • Suite 200
  • Carlsbad
  • California
  • 92008
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LCTXNYSEAM (NYSE MKT LLC)YesCommon SharesUSUSDMar 1992
BT3DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 1992
LCTXTASE (The Tel-Aviv Stock Exchange)YesCommon SharesILILSMar 1992

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 07:59
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.